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Background Long-term health outcomes in cohorts of workers from the electricity supply industry have been 
studied.
Aims The aim of the study was to examine updated cancer incidence findings among a cohort of UK elec-
tricity generation and transmission workers.
Methods Cancer morbidity experienced by 81 616 employees of the former Central Electricity Generating 
Board of England and Wales was investigated for the period 1973–2015. All employees had worked 
for at least 6 months with some employment between 1973 and 1982. Standardized registration 
ratios (SRRs) were calculated based on national rates.
Results Overall cancer morbidity was slightly below expectation in males. Significant excesses were found in 
male workers for mesothelioma (observed [Obs] 763, SRR 326), skin cancer (non-melanoma) (Obs 
5616, SRR 106), and prostate cancer (Obs 4298, SRR 106), and in female workers for cancer of the 
small intestine (Obs 13, SRR 220), nasal cancer (Obs 11, SRR 407), and breast cancer (Obs 758, 
SRR 110). More detailed analyses showed important contrasts, particularly for mesothelioma, lung 
cancer, skin cancer, prostate cancer and breast cancer.
Conclusions A clear occupational excess of mesothelioma was not matched by a corresponding excess of asbestos-
induced lung cancer. Confident interpretation of the excesses of cancers of the nasal cavities and small 
intestine is not possible, although occupational exposures received in this industry may well not be 
involved. An excess of skin cancer in transmission workers may be associated with outdoor working.
Key words Cancer incidence; electricity supply industry.
Introduction
A cohort of UK electricity supply industry workers (power 
stations, substation or transmission sites, non-operational 
sites) was established in the 1980s to investigate whether 
such work was the cause of non-malignant lung disease. 
More recently, concerns that electromagnetic field (EMF) 
exposure may cause brain cancer, leukaemia, or have a role 
in neurodegenerative or cardiovascular diseases have been 
the focus of epidemiological studies in this industry [1–8], 
and a number of reviews are available [9–12]. Kheifets et al. 
[12] concluded that the literature on occupational EMF 
exposure ‘did not indicate strong or consistent associations 
with cancer’. Other exposures in the industry have been 
little considered. In 2010, cancer registration (incidence) 
data were incorporated into the UK cohort, and an analysis 
of cancer incidence for the period 1973–2008 was pub-
lished in 2012 [13]. This report showed an occupational 
excess of mesothelioma but no excess of asbestos-induced 
lung cancer. There were also significant excesses of nasal 
cancer, and small intestine cancer in female employees; 
based on relatively small numbers of cases. An updated 
analysis of these UK data has been carried out aiming to 
provide a more complete monitoring of cancer risks in this 
cohort, and to identify any other types of cancer that merit 
further investigation. Details of exposure to electric and 
magnetic fields in this industry have been described before 
[5,14]. A long list of other occupational exposures present 
in parts of the industry before 1997 has also been pub-
lished [15]. The cohort has been used in the past to test 
hypotheses [5–8], but this report is designed to generate 
rather than test occupational hypotheses.
Methods
The study population and computerized data have been 
described previously [5–8,13]. The cohort comprises 
83 284 employees (72 352 males and 10 932 females) 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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of the former Central Electricity Generating Board 
(CEGB) of England and Wales. The earlier cohort [13] 
has been reduced in size because 639 employees who 
moved to Scotland had to be deleted from the study files 
because a Data Sharing Agreement (DSA) is no longer 
in place with the General Register Office (GRO) for 
Scotland. This small percentage change is not expected 
to result in an important selection bias. All employees 
had a minimum of 6 months of employment with some 
period of employment between 1973 and 1982. The total 
cohort was subdivided into three categories based on the 
work location (industry sector) of the first known job: 
power stations (n = 52 928), substation or transmission 
sites (n = 3359), and non-operational sites (n = 21 966). 
There were a further 3985 employees for whom no job 
history was available and 1046 employees whose work 
history could not be classified. These latter two were 
combined into a single ‘unclassifiable industry sector’ 
category.
NHS Digital (and its forerunners) supplied mor-
tality and cancer registration follow-up particulars. 
NHS Digital is the national provider of information, 
data and IT systems for commissioners, analysts and 
clinicians in health and social care in England. By the 
study closing date (31 December 2015), 36 302 workers 
had died, 1090 workers had emigrated, 44 543 workers 
were traced alive and 1349 workers were untraced. After 
excluding the 1349 untraced workers and 319 workers 
whose deaths had been identified only by the former UK 
Department of Health and Social Security (DHSS) (and 
for whom cancer incidence data were not available), a 
total of 81 616 employees were considered for the cancer 
incidence analysis.
Cancer incidence in the cohort was compared with ex-
pected values based on incidence rates for England and 
Wales, taking sex, age and calendar period into account; 
calculations were carried out with the EPICURE pro-
gramme [16], using the double precision DOS version 
2.12 (2002) of DATAB. Study subjects were entered into 
the person-years-at-risk (pyr) after the first 6  months 
of employment or the date of computerization for 
the region of their employment, whichever was later. 
Individuals were removed from the pyr on the date of 
death, date of emigration or the end of 2015, whichever 
was the earlier. Study subjects did not contribute to ob-
served or expected numbers after their 100th birthday, 
in case some subjects in later age groups had been traced 
alive incorrectly.
Standardized registration ratios (SRRs) by malig-
nant neoplasm (MN) site were provided by the ratios 
of observed and expected numbers of cancer cases to a 
baseline of 100. P-values and 95% confidence intervals 
(CIs) were calculated on the basis that cancer occurs as 
a Poisson process, and all tests of statistical significance 
were two-tailed. More detailed analyses were also car-
ried out by year of hire (1926–59, 1960–69, 1970–82), 
period from hire irrespective of how long any individual 
works in the industry (0–19, 20–29, 30–39, ≥40 years), 
period from leaving employment (still employed or left 
employment <10 years ago, left employment 10–19 years 
ago, left employment 20–29 years ago, left employment 
>30 years ago), duration of employment (<10 years (i.e. 
Key learning points
What is already known about this subject:
 • This survey was set up in the 1980s to learn more about the long-term health of employees in the UK electricity 
supply industry.
 • In the intervening years, a series of 11 papers have found no convincing links between estimated exposure to 
magnetic fields and a number of health outcomes.
 • This new report was prepared to provide a more complete assessment of cancer risks in the cohort, incorporating 
a further 6 years of follow-up data.
What this study adds:
 • The cohort continues to experience an occupational excess of mesothelioma without any matching excess of 
lung cancer.
 • Outdoor working may have been a factor in excess of skin cancer (non-melanoma).
 • Excesses in females for nasal cancer and cancer of the small intestine were not matched by similar findings in 
males.
What impact this may have on practice, policy or procedure:
 • The findings reinforce the need for regulations that protect workers from asbestos exposure and the advice 
given to outdoor workers concerning sun exposure.
 • The findings provide indirect evidence that further control of magnetic fields exposure is probably not needed.
 • Employees who have been exposed to asbestos should continue to be encouraged not to smoke to reduce the 
risk of asbestos-related lung cancer.
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0.5–9.9 years), 10–19 years, ≥20 years), industry sector of 
first known employment in the industry (power stations, 
transmission facilities, non-operational sites), and type 
of work (manager, engineer, administrative and clerical, 
industrial worker, building construction). For the first 
four variables, tests for trend (linear component) [17] 
were carried out (e.g. was there a tendency for SRRs to 
increase or decrease with year of hire). Tests for hetero-
geneity [17] were carried out for the last two variables 
(e.g. could the differences in SRRs by industry sector 
represent no more than random variation in sub-groups). 
These tests assumed a similar null hypothesis: no trend 
and homogeneous SRRs. All analyses only consider con-
temporaneous categories for the summation of pyr.
This study was established with the approval of 
the Central Ethical Committee of the British Medical 
Association, and the author is accredited by the Office 
for National Statistics as an ‘Approved Researcher’. 
The current protocol was approved by the University 
of Birmingham’ Science, Technology, Engineering and 
Mathematics Ethical Review Committee (project code 
ERN_13-0676). Computer analyses were carried out 
in accordance with the terms of an active Data Sharing 
Agreement (DSA) with NHS Digital. A privacy notice is 
available at http://www.emfs.info/research/studies/cegb-
cohort/update/. One condition of the DSA was that find-
ings based on fewer than five observed cases would not 
be published. The study has never contained any infor-
mation on ethnicity, medical histories or lifestyle factors, 
and since 2013, no information on names, addresses, 
National Insurance or NHS numbers.
Results
Table 1 shows site-specific MNs for male and female em-
ployees. Compared with national rates, all MNs combined 
were slightly (though highly significantly, P  <  0.001) 
below expectation for males (Obs 19 223, SRR 97) and 
close to expectation for females (Obs 2149, SRR 101). 
In males, significant deficits are shown for MNs of the 
tongue, mouth, pharynx, oesophagus, rectum, liver, pan-
creas, larynx and lung. Significant excesses are shown 
for skin cancer (excluding melanoma) (Obs 5616, SRR 
106, P  <  0.001), mesothelioma (Obs 763, SRR 326, 
P  <  0.001) and prostate cancer (Obs 4298, SRR 106, 
P < 0.001). In females, a significant deficit is shown for 
MN of the cervix, and significant excesses are shown for 
MN of the small intestine (Obs 13, SRR 220, P < 0.05), 
nasal cavities (Obs 11, SRR 407, P < 0.001) and breast 
(Obs 758, SRR 110, P < 0.01). Findings for MN of the 
brain and all leukaemia combined were unexceptional.
Findings in Table 1 were examined to ascertain 
whether smoking-related cancers other than lung cancer 
were in deficit in male employees. For other cancer sites 
identified as capable of being caused by smoking cigar-
ettes (oral cavity, pharynx, nasal cavity and paranasal 
sinuses, larynx, oesophagus, stomach, pancreas, liver, 
kidney, ureter, urinary bladder, myeloid leukaemia) 
[18], the SRR was significantly below expectation (Obs 
4680, SRR 91, 95% CI 88–93). The SRR for cancers 
not judged to be capable of being caused by smoking 
(and excluding skin other than melanoma and unspeci-
fied neoplasms) was significantly elevated (Obs 10 587, 
SRR 107, 95% CI 105–109). However, the SRR for can-
cers not considered to be caused by smoking or asbestos 
exposures (further exclusion of mesothelioma) was not 
significantly elevated (SRR 101, 95% CI 99–104).
Findings from Table 1 were reviewed and all MNs, 
mesothelioma, MN of the skin (excluding melanoma) 
lung, breast and prostate in male workers, and MN of 
the small intestine, nasal cavities and breast in female 
workers were selected for further investigation.
Table 2 shows observed and expected numbers of 
cancer registrations for all MNs in male workers by year 
of hire, period from hire, period from leaving employ-
ment, duration of employment, industry sector and type 
of work. There was a highly significant positive trend 
with the period from leaving employment although this 
was dependent on a low SRR in a single category (still 
employed and left less than 10  years ago). There was 
also highly significant heterogeneity in the findings by 
industry sector and type of work; SRRs were lower in 
transmission and non-operational site workers compared 
with those in power station workers, and SRRs were 
lower in managers, engineers and clerical (including ad-
ministrative) workers compared with those in industrial 
and construction workers.
Table 2 shows findings for MN of the skin (excluding 
melanoma) in male workers. A significant negative trend 
is shown with year of hire (SRRs tend to be lower with 
more recent hires), and a significant positive trend is 
shown with a period from hire. There was also highly 
significant heterogeneity in the findings by industry 
sector and type of work; SRRs were higher in transmis-
sion workers compared with those in power station and 
non-operational site workers and SRRs were higher in 
engineers and clerical workers compared with those in 
industrial and construction workers.
Table 3 shows findings for mesothelioma and MN of 
the lung in males; for mesothelioma, there was a highly 
significant negative trend with year of hire and a highly 
significant positive trend with period from hire (SRRs 
were higher with later periods from hire). There was a 
highly significant positive trend with duration of employ-
ment. There was also highly significant heterogeneity in 
the findings by industry sector and type of work; SRRs 
were higher in power station workers compared with 
those in transmission and non-operational site workers, 
and SRRs were lower in clerical workers compared with 
those in all other types of work. Very different patterns 
are shown for MN of the lung. There was a highly signifi-
cant positive trend with year of hire (SRRs were higher 
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Table 1.  Incidence of MNs in UK Electricity Generation and Transmission workers, 1973–2015 (71 185 males, 10 431 females)
Site of MN ICD-10 Males Females
Obs Exp SRR 95% CI Obs Exp SRR 95% CI
Lip C00 30 31.7 95 65–133 Sup.a    
Tongue C01–02 75 108.7 69 55–86 11 7.6 145 76–252
Mouth C03–06 74 113.1 65 52–82 10 8.8 114 58–203
Salivary gland C07–08 41 40.7 101 73–135 Sup.a    
Pharynx C09–14 104 163.8 63 52–77 Sup.a    
Oesophagus C15 574 646.4 89 82–96 28 35.4 79 54–113
Stomach C16 899 902.4 100 93–106 44 41.2 107 79–142
Small intestine C17 61 59.7 102 79–130 13 5.9 220 123–367
Large intestine C18 1587 1604.5 99 94–104 158 155.3 102 87–119
Rectum C19–21 1052 1134.6 93 87–98 69 79.3 87 68–110
Liver C22 185 242.9 76 66–88 13 15.9 82 45–136
Gallbladder C23–24 98 90.0 109 89–132 16 12.2 131 78–208
Pancreas C25 457 551.9 83 75–91 56 53.6 105 80–135
Other digestive C26 32 39.0 82 57–114 Sup.a    
Nose and sinuses C30–31 34 36.2 94 66–130 11 2.7 407 214–708
Larynx C32 186 279.6 67 57–77 5 6.5 77 28–171
Lung and bronchus C33,34 3162 3909.3 81 78–84 240 243.1 99 87–112
Bone C40,41 22 26.1 84 54–126 Sup.a    
Melanoma C43 444 446.0 100 91–109 69 67.4 102 80–129
Skin, other C44 5616 5288.9 106 103–109 494 464.4 106 97–116
Mesothelioma C45 763 234.0 326 304–350 Sup.a    
Connective tissue C47,C49 98 96.3 102 83–124 10 9.3 108 55–192
Peritoneum C48 21 20.4 103 65–155 7 5.3 132 58–261
Breast C50 52 42.0 124 93–161 758 688.9 110 102–118
Cervix C53 — —   38 59.3 64 46–87
Uterus C54 — —   95 103.0 92 75–112
Ovary C56 — —   116 106.5 109 90–130
Prostate C61 4298 4073.3 106 102–109 — —   
Testis C62 89 105.9 84 68–103 — —   
Other genital rem.b C51–63 66 66.7 99 77–125 24  24.0 100 66–147
Kidney C64 495 520.6 95 87–104 31 35.7 87 60–122
Bladder C67 1257 1249.9 101 95–106 39 43.7 89 64–121
Other urinary C65–66, C68 117 103.8 113 94–135 7 5.8 121 53–239
Eye C69 34 34.7 98 69–135 5 3.7 135 50–300
Brain C70–72 335 324.9 103 93–115 21 29.6 71 45–107
Thyroid C73 48 49.5 97 72–128 11 16.3 67 35–117
Other endocrine glands C74–75 12 14.6 82 45–140 Sup.a    
Secondary and unspecified cancers C76–80 794 828.2 96 89–103 82 81.9 100 80–124
Hodgkin’s disease C81 73 81.5 90 71–112 9 8.1 111 54–204
Non-Hodgkin’s lymphoma C82–85 695 680.3 102 95–110 64 67.5 95 74–120
Multiple myeloma C90 311 299.5 104 93–116 22 26.1 84 54–126
Leukaemia C91–95 497 504.8 98 90–107 42 39.1 107 78–144
 Acute lymphoid leukaemia C91.0 12 15.8 76 41–129 Sup.a    
 Chronic lymphoid leukaemia C91.1 238 212.4 112 98–127 15 13.6 110 64–178
 Acute myeloid leukaemia C92.0, C92.5 134 156.0 86 72–101 19 14.6 130 81–200
 Chronic myeloid leukaemia C92.1 48 49.0 98 73–129 Sup.a    
 Other leukaemia rem.b C91–95 65 71.7 91 71–115 5 5.0 100 37–222
All MNs 140–209c 19 223 19 822.0 97 96–98 2149 2122.9 101 97–106
aSup = findings supressed because of confidentiality concerns about ‘disclosive’ data.
brem = remainder.
cExcluding ‘skin, other’, ICD-10 C44.
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with more recent decades of hire), and a highly significant 
negative trend with period from hire (SRRs were lower 
with later periods from hire). There was a highly signifi-
cant negative trend with duration of employment. There 
was also highly significant heterogeneity in the findings 
by industry sector and type of work; SRRs were higher in 
power station workers compared with those in transmis-
sion and non-operational site workers, and SRRs were 
lower in managers, engineers and clerical (including ad-
ministrative) workers compared with those in industrial 
and construction workers.
 Table 4 shows findings for MN of the prostate. There 
was a significant positive trend with duration of employ-
ment. There was also highly significant heterogeneity in the 
findings by type of work; SRRs were higher in engineers and 
clerical workers compared with those in other types of work.
Table 2.  Incidence of all MNs combined (excluding skin other than melanoma) and MN of the skin (excluding melanoma) in 71 185 
male UK Electricity Generation and Transmission workers, by year of hire, period from hire, period from leaving employment, duration 
of employment, industry sector and type of work, 1973–2015
All MNs MN of the skin 
Obs  Exp  SRR 9 5% CI  Obs  Exp  SRR 95% CI
Year of hire
 1926–59 5850 6014.9 97 95–100 1668 1525.5 109 104–115
 1960–69 7764 7957.0 98 95–100 2302 2123.0 108 104–113
 1970–82 5609 5850.1 96 93–98 1646 1640.4 100 96–105
Test for trend    P = NS    P = *
Period from hire (years) 
 0–19 2006 2076.6 97 92–101 305 329.0 93 83–104
 20–29 3514 3793.1 93 90–96 821 755.8 109 101–116
 30–39 6011 6099.1 99 96–101 1576 1589.3 99 94–104
 ≥40 7692 7853.2 98 96–100 2914 2614.7 111 108–116
Test for trend   P = NS   P = **
Period from leaving employment (years)
 <10a 4837 5373.1 90 88–93 872 898.0 97 91–104
 10–19 6865 6859.1 100 98–103 1780 1615.3 110 105–115
 20–29 5626 5686.7 99 96–102 2114 1949.7 108 104–113
 ≥30 1895 1903.2 100 95–104 850 825.8 103 96–110
Test for trend   P = ***   P = NS
Duration of employment (years)
 <10 3564 3624.2 98 95–102 976 967.4 101 95–107
 10–19 6616 6715.7 99 96–101 1887 1760.4 107 102–112
 ≥20 9043 9482.1 95 93–97 2753 2561.1 108 104–112
Test for trend    P = NS    P = NS
Industry sector
 Power stations 13 745 13 570.1 101 100–103 3757 3599.5 104 101–108
 Transmission  857 980.6 87 82–93 348 270.2 129 116–143
 Non-operational 3508 4268.1 82 80–85 1302 1188.3 110 104–116
 Unclassifiableb 1113 1003.1 111 105–118 209 230.9 91 79–103
Test for heterogeneity   P = ***    P = ***
Type of work
 Managers 196 260.4 75 65–86 69 69.6 99 78–125
 Engineers 4294 5092.0 84 82–87 1703 1449.5 118 112–123
 Admin, clerical 1034 1232.4 84 79–89 358 325.8 110 99–122
 Industrial 12 469 12 146.2 103 101–105 3266 3192.3 102 99–106
 Building, constr. 250 217.0 115 102–130 52 54.6 95 72–124
 Not known 980 873.9 112 105–119 168 197.1 85 73–99
Test for heterogeneity   P = ***   P = ***
Total 19 223 19 822.0 97 96–98 5616 5288.9 106 103–109
NS, not significant.
aIncludes still employed.
bUnclassifiable work history or no work history.
*P < 0.05, **P < 0.01, ***P < 0.001, 
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Corresponding findings for MN of the small intestine 
and the nasal cavities in female workers were also calcu-
lated. Both findings were based on small numbers and 
are not tabulated because of concerns about ‘disclosive’ 
data. There were no significant trends or heterogeneity 
in the findings.
Table 5 shows findings for MN of the breast for male 
and female workers. There was significant heterogeneity 
in the findings for females by type of work; SRRs were 
higher in clerical workers and workers with unknown job 
type compared with those found in engineers and indus-
trial workers.
Discussion
Overall, this study showed a clear occupational excess of 
mesothelioma with no matching excess of lung cancer, 
and unexceptional findings for brain tumours and 
Table 3.  Incidence of mesothelioma and MN of the lung in 71 185 male UK Electricity Generation and Transmission workers, by year 
of hire, period from hire, period from leaving employment, duration of employment, industry sector and type of work, 1973–2015
Mesothelioma  MN of the lung 
Obs  Exp  SRR 95% CI  Obs  Exp  SRR 95% CI
Year of hire
 1926–59 311 65.9 472 422–527 999 1330.8 75 71–80
 1960–69 334 97.1 344 309–382 1297 1587.4 82 77–86
 1970–82 118 71.0 166 138–198 866 991.1 87 82–93
Test for trend  P = ***   P = ***
Period from hire (years) 
 0–19 29 14.7 197 135–280 500 548.4 91 83–99
 20–29 72 38.5 187 147–234 741 847.0 87 81–94
 30–39 221 72.6 304 266–347 942 1142.2 82 77–88
 ≥40 441 108.2 408 371–447 979 1371.7 81 67–76
Test for trend  P = ***   P = ***
Period from leaving employment (years)
 <10a 125 44.6 280 234–333 1125 1420.5 79 75–84
 10–19 282 80.6 350 311–393 1042 1300.8 80 75–85
 20–29 267 80.2 333 295–375 739 904.8 82 76–88
 ≥30 89 28.5 312 252–383 256 283.2 90 80–102
Test for trend  P = NS   P = NS
Duration of employment (years)
 <10 70 41.3 170 133–213 644 658.3 98 90–106
 10–19 228 77.3 295 259–335 1191 1336.1 89 84–94
 ≥20 465 115.4 403 368–441 1327 1914.9 69 66–73
Test for trend   P = ***   P = ***
Industry sector
 Power stations 616 160.9 383 354–414 2416 2690.2 90 86–93
 Transmission 20 12.2 164 103–249 119 190.5 62 52–74
 Non-operational 92 52.0 177 143–216 384 803.1 48 43–53
 Unclassifiableb 35 8.9 393 278–541 243 225.4 108 95–122
Test for heterogeneity P = ***   P = ***
Type of work
 Managers 10 2.9 345 175–615 17 56.2 30 18–47
 Engineers 209 66.2 316 275–361 381 940.2 41 37–45
 Admin, clerical 7 13.5 52 23–103 138 245.0 56 48–56
 Industrial 486 141.3 344 314–376 2356 2421.8 97 93–101
 Building, constr. 19 2.4 792 491–1213 45 46.1 98 72–130
 Not known 32 7.6 421 293–587 225 199.9 113 99–128
Test for heterogeneity P = ***   P = ***
Total 763 234.0 326 304–350 3162 3909.3 81 78–84
 NS, not significant.
aIncludes still employed.
bUnclassifiable work history or no work history.
***P < 0.001. 
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leukaemia. Strengths of the study include its size and 
length of follow-up with a correspondingly large number 
of cancer cases, including rare cancers. Limitations in-
clude the absence of smoking data, other lifestyle data 
and detailed pre-1973 work histories. The latter meant 
that first known job had to be used to categorize indi-
viduals by industry sector and type of work (55% of 
the cohort had some employment within the industry 
before personnel records were computerized). Some 
misclassification in the sub-group analyses will have oc-
curred although only 2% of power station workers had 
later recorded periods of working in the transmission 
sector and 6% of transmission workers had later re-
corded periods of working in power stations.
Incidence of all MNs combined was below expected 
in males, and morbidity from lung cancer was markedly 
below expectation. Findings for other smoking-related 
cancers were consistent with the hypothesis that this 
Table 4.  Incidence of MN of the prostate in 71 185 male UK Electricity Generation and Transmission workers, by year of hire, period 
from hire, period from leaving employment, duration of employment, industry sector and type of work, 1973–2015
MN of the prostate
 Obs  Exp  SRR 95% CI
Year of hire
 1926–59 1254 1167.5 107 102–114
 1960–69 1789 1660.6 108 103–113
 1970–82 1255 1245.2 101 95–107
Test for trend  P = NS
Period from hire (years) 
 0–19 153 143.4 107 91–125
 20–29 548 565.4 97 89–105
 30–39 1448 1356.9 107 101–112
 ≥40 2149 2007.6 107 103–112
Test for trend  P = NS
Period from leaving employment (years)
 <10a 516 503.3 103 94–112
 10–19 1719 1540.7 112 106–117
 20–29 1560 1510.7 103 98–109
 ≥30 503 518.6 97 89–106
Test for trend  P = NS
Duration of employment (years)
 <10 703 724.7 97 90–104
 10–19 1417 1354.4 105 99–110
 ≥20 2178 1994.2 109 105–114
Test for trend    P = **
Industry sector
 Power stations 2887 2779.4 104 100–108
 Transmission 213 207.1 103 90–117
 Non-operational 1002 899.9 111 105–118
 Unclassifiableb 196 186.8 105 91–120
Test for heterogeneity  P = NS
Type of work
 Managers 47 52.1 90 67–119
 Engineers 1300 1108.9 117 111–124
 Admin, clerical 278 246.8 113 100–127
 Industrial 2454 2459.5 100 96–104
 Building, constr. 47 42.9 110 81–144
 Not known 172 163.1 106 91–122
Test for heterogeneity  P = ***
Total 4298 4073.3 106 102–109
NS, not significant.
aIncludes still employed.
bUnclassifiable work history or no work history.
**P < 0.01, ***P < 0.001. 
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skilled workforce had below average smoking habits; a 
low prevalence of smoking in this industry has been pub-
lished previously [13].
Mesothelioma was significantly elevated for males 
in all industry sectors and in all types of work except 
administration and clerical work; with little sign of the 
effects of asbestos risk having played itself out (2006–
2010: Obs 159, SRR 317, 95% CI 271–369; 2011–2015: 
Obs 169, SRR 298, 95%CI 255–345). The most likely 
explanation for the excess of mesothelioma in transmis-
sion and non-operational site workers is occasional or 
earlier (pre-1973) periods of working at power stations 
where asbestos was used to lag pipes and boilers [13]. 
It is estimated that in the UK in 2004 there were 1937 
mesotheliomas and 2223 lung cancer cases caused by 
earlier asbestos exposure [19]. This estimate considers 
that there will be 1.1 lung cancers for every mesothelioma 
caused by asbestos. This 1.1:1 ratio does not seem to be 
Table 5.  Incidence of MN of the breast in 71 185 male and 10 431 female UK Electricity Generation and Transmission workers, by 
year of hire, period from hire, period from leaving employment, duration of employment, industry sector and type of work, 1973–2015
Males Females
Obs  Exp  SRR 95% CI  Obs  Exp  SRR 95% CI
Year of hire
 1926–59 18 12.5 144 88–223 51 38.3 133 100–174
 1960–69 19 16.8 113 70–173 145 128.5 113 96–132
 1970–82 15 12.8 117 68–189 562 522.1 108 99–117
Test for trend  P = NS   P = NS
Period from hire (years) 
 0–19 6 4.7 128 52–266 168 152.7 110 94–128
 20–29 11 8.2 134 71–233 225 209.0 108 94–122
 30–39 13 12.9 101 56–168 267 241.0 111 98–125
 ≥40 22 16.2 136 87–202 98 86.2 114 93–138
Test for trend   P = NS   P = NS
Period from leaving employment (years)
 <10a 16 11.8 136 80–216 179 164.7 109 94–126
 10–19 13 14.0 93 52–155 228 194.1 118 103–134
 20–29 16 12.3 130 77–207 213 214.7 99 87–113
 ≥30 7 3.9 180 79–355 138 115.5 120 101–141
Test for trend   P = NS   P = NS
Duration of employment (years)
 <10 10 7.9 127 64–226 428 400.9 107 97–117
 10–19 16 14.3 112 66–178 240 211.0 114 100–129
 ≥20 26 19.8 131 88–190 90 77.0 117 95–143
Test for trend   P = NS   P = NS
Industry sector
 Power stations 33 28.7 115 80–160 273 253.6 108 95–121
 Transmission 2 2.1 95 16–315 11 12.5 88 46–153
 Non-operational 16 9.1 176 104–279 417 374.0 112 101–123
 Unclassifiableb Sup.c    57 48.8 117 89–150
Test for heterogeneity  P = NS   P = NS
Type of work
 Managers Sup.c    Sup.c    
 Engineers 18 10.8 167 102–258 13 13.2 98 55–164
 Admin, clerical 5 2.6 192 70–426 566 496.0 114 105–124
 Industrial 28 25.7 109 74–155 130 140.0 93 78–110
 Building, constr. Sup.c    Sup.c    
 Not known Sup.c    47 38.4 122 91–161
Test for heterogeneity  P = NS   P = *
Total 52 42.0 124 93–161 758 688.9 110 102–118
NS, not significant.
aIncludes still employed.
bUnclassifiable work history or no work history.
cSup = findings suppressed because of confidentiality concerns about ‘disclosive’ data.
*P < 0.05. 
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applicable to the UK electricity supply industry workers. 
The numbers in this study are so large that the absence 
of a lung cancer excess related to asbestos is very unlikely 
to be a chance finding. Low smoking prevalence in the 
cohort explains this to some extent, but there must be 
other unrecognized factors in operation.
The excess of small intestine cancer in female em-
ployees with no comparable excess in male employees 
indicates that occupational exposures are not important 
in this excess, as it is difficult to imagine exposures in 
this industry that would be unique to female workers. 
There were no important contrasts in the more detailed 
analyses for this excess. Risk factors for small intestine 
cancer have been little studied, but there is some evi-
dence that ‘risk factors are similar to those seen with 
colon cancer (meat intake) and stomach cancer (salt-
cured and smoked foods)’ [20]. As findings for MN of 
the large intestine and stomach in females were close to 
expectation in this study, they do not offer any indirect 
support for a dietary explanation for the excess MN of 
the small intestine, and confident interpretation of the 
excess is not possible.
There was a marked excess of nasal cancer in fe-
male employees with no matching excess in male em-
ployees. Nasal cancer, particularly adenocarcinoma, is 
associated with some occupational exposures, including 
hard wood dust, leather dust and hexavalent chromium 
exposure [21]. Exposures to leather dust and hexava-
lent chromium are not present in the industry under 
study, although there are carpentry shops in power sta-
tions. However, none of the female cases ever worked 
in such shops and bystander exposure seemed an un-
likely explanation for this excess when there was no 
corresponding excess in male workers. There were no 
important contrasts in the detailed analyses that were 
carried out for this excess, and it seems unlikely that this 
excess is due to occupational exposures in this industry. 
Nevertheless, it remains possible that some of the nasal 
cancers in females are occupational in origin due to un-
recognized factors in this industry or unknown employ-
ment in other industries.
Exposure to sunlight is an accepted risk factor for skin 
cancer (non-melanoma), and the higher risk in transmis-
sion workers could be attributable to outdoor working. 
Unfortunately, individual data on occupational and non-
occupational sun exposure are not available for study, but 
general information on dress habits and outdoor working 
in the industry could be examined in future studies in 
terms of skin cancer fourth digit codes (e.g. wearing of 
short-sleeved shirts and skin cancer of the upper limb 
ICD-10 C44.6).
Several studies of workers potentially exposed to 
EMF have reported increased risks of male breast cancer 
[22–25], although three cohort studies of electric utility 
workers reported no overall excess [2–4]. There were no 
important contrasts in more detailed analyses that were 
carried out for male breast cancer in this study. The ex-
cess of breast cancer in female workers was based, mainly 
on an excess in administrative and clerical workers; 
making occupational exposures involvement in this ex-
cess unlikely.
There was a significant trend for prostate cancer in 
relation to duration of employment. The reason for this 
is unclear, but it is possible that sedentary working is in-
volved [26]. Examination of this hypothesis would in-
volve collection of additional work history data, possibly 
as part of a nested case–control study.
In conclusion, the overall elevated incidence found 
for mesothelioma almost certainly reflects the late health 
effects of earlier incidental asbestos exposure in this in-
dustry. This report highlights the need for further re-
search in a number of areas, including the conditions 
that lead to some asbestos-exposed cohorts not having 
clear excesses of asbestos-induced lung cancer. It would 
be useful to review incident cancers of the nasal cavities 
and the small intestine in female workers in the electricity 
supply industry in other countries. Nested case–control 
studies could also be usefully carried out on skin cancer 
and prostate cancer. Such studies would require collec-
tion of additional data, but permissions are currently not 
in place to obtain such data.
These findings have implications for clinicians and 
policymakers; they reinforce the importance of regula-
tions that protect workers from asbestos exposure and 
the advice given to outdoor workers concerning sun ex-
posure. They provide indirect evidence that further con-
trol of magnetic fields exposure is probably not needed, 
and indicate that employees who have been exposed to 
asbestos should continue to be encouraged not to smoke 
to reduce the risk of asbestos-related lung cancer.
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